Review of the Cheshire and Merseyside Commissioning Policy 2014/15 St Helens Council Overview and Scrutiny Committee December 3 rd 2018 Dr Ruth Hunter
Topics to be covered today • What is the Commissioning Policy? • Why do we have it? • How does it work? Why are we reviewing the policy? • • How have we conducted the review and where are we up to? • What engagement are we doing?
What is the Commissioning Policy Terminology The policy contains guidance about procedures* which are not routinely undertaken in the NHS and also refers to medicines or equipment which is not commonly prescribed in the NHS. Policy covers a wide range of specialties and sets out the criteria for patients having these procedures and how they must be met. Examples of clinical specialties the policy Examples of procedures in the policy covers diabetes Continuous glucose monitoring Orthopaedics Secondary Care Administered Steroid Peripheral Joint Injections Urology Policy for Prostatism/Lower Urinary Symptoms in Men Ophthalmology Cataract * The presentation will use the term procedures for simplicity
Why do we have the policy? Ensuring that public money is used to give the most health gain possible for all the population Not all the procedures work equally well for all • people • Problem would have solved itself without any intervention anyway • Very expensive and may not always give the desired result • Procedure is recommended by NICE** in limited circumstances • Little evidence of efficacy, limited research done **NICE – National Institute for Health and Clinical Excellence
Commissioning policy review – why now? Current policy Method – a 6 phase review • 3 year policy needs updating • CCG signed up for first 3 phases • Is the policy all up to date • Phase 1 and 2 completed • Confusing and hard to follow • Phase 3 underway • Updated guidance on procedures eg from NICE • Lacks clarity • Contradictory
Terminology • The policy sets out criteria that must be met for the patient to have the procedure • CBCTs can be carried out if a patient meets a set of criteria • Or they can be carried out if funding is agreed via an individual funding request But some of the procedures in the policy are • Restricted - not routinely commissioned procedures (NRCs) – there is only one route to use for an NRC and this is an application to the IFR panel
Cost of PLCPs and NRCs 17/18 PLCP NRC Number in 17/18 4562 1144 Cost in 17/18 7,994,329 1,589,418
Example
What if the criteria are not met for a CBCT or the procedure is for an NRC? • Clinician submits an Individual Funding Request – IFR • IFR details why the patient’s case is exceptional • Panel considers the application – is this case truly exceptional • Makes a decision • Informs referrer eg GP or consultant • Informs patient • There is an appeal process • The CCG’s IFR process is run by Midlands and Lancashire CSU This process is also used for all NRCs in the commissioning policy
The engagement process The engagement process The engagement process The engagement process • Initial plan – pre-consultation engagement for 8 policies and the assisted conception policy • Will begin December to mid January 2019 • Consider feedback and then update the equality impact and risk report: • formal consultation may follow avoiding purdah • See below how levels of engagement are defined. Engagement Description Level 1 Survey posted online and offline with no target 2 Survey posted online and offline, targeted at specific cohorts of people through social media and support groups/charities 3 Survey posted online and offline, targeted at specific cohorts of people through social media and support groups/charities with additional face to face targeted engagement The word engagement is used to cover any engagement of consultation activities for clarity The word engagement is used to cover any engagement of consultation activities for clarity The word engagement is used to cover any engagement of consultation activities for clarity The word engagement is used to cover any engagement of consultation activities for clarity 10
Engagement methodology continued • Engagement Audiences include; • Clinicians - through out the policy review process so far, clinicians have been consulted where required in their expert fields. Clinicians will also have the opportunity to provide feedback during any engagement periods. • Public – public engagement will be targeted through social media and groups/charities for those policies which require it (detailed policy plans available upon request). A survey will be available for public to feedback on policy changes. Information will be provided online on each CCG website as well as leaflets and poster in GP surgeries and providers and some events. • Internal/Staff - Existing channels of staff communication both in primary and secondary care will be utilized including staff forums, staff intranet and staff newsletters • Stakeholders – key stakeholders including Local Authorities, Voluntary Sector Organisations and patient support groups, will be provided with the detailed paper outlining engagement. 11
Engagement materials and channels – as appropriate • Survey – Online, Hard copy available at on request from some GP practice, over the phone (0121 612 3806) or your local CCG • Dedicated website landing pages on each CCG site, outlining the current policies out for engagement and the purpose of the project • Voluntary organisations/patient support groups/stakeholders such as MPs, councillors engagements – face to face meetings and phone calls • Targeted engagement where needed • Patient leaflet, posters, (for consultation only) FAQ’s and ‘Plain English’ documents per policy. • Social media – Twitter and Facebook. • Press releases – proactive PR; launch, mid and summary • Dedicated email and phone contact point • Information available in other languages and formats upon request • Reactive media statements signed off prior to engagement 12
Which policies are we engaging about? • Treatments for Dupuytrens Disease • Botulinum Toxin A & B • Policy for Prostatism/Lower Urinary Symptoms in Men • Secondary Care Administered Steroid Peripheral Joint Injections • Cough Assist Devices • Continuous Glucose Monitoring • Insulin pumps • Transanal irrigation • Assisted conception policy
Thank you Any questions
Recommend
More recommend
